Company Performance Metrics
Guus Simons: CEO & Founder
PathoFinder offers a new generation of comprehensive molecular diagnostics for syndromic infectious disease panels. Our state-of-the-art multiplex PCR technologies enable a rapid detection and identification of multiple human pathogens in clinical specimens.
PathoFinder products are based on our proprietary SmartFinder and MultiFinder multiplex
PCR-technologies or on Real Time PCR. With PathoFinder's multiplex PCR products, up to 22 pathogens can be readily identified in a single, easy to perform multiplex PCR assay. Our RealAccurate® products include mono- duplex and quadruplex Real Time PCR assays.
Targeted human infectious diseases include: Respiratory Tract Infections, Gastroenteritis, Viral Meningitis, Sexually Transmitted Diseases and Human Papilloma Virus Infections.
PathoFinder's multiplex PCR-products save time, allow for automation and are cost-effective, and thus address the three major aspects of introducing comprehensive molecular diagnostics in the daily clinical routine.
The company's products are developed and produced in an ISO 13485:2003 environment and are validated on all relevant QCMD panels to ensure optimal quality, sensitivity and specificity.
